SMS. Yu. Mogilevskyy

S. Yu. Mogilevskyy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


S. Yu. Mogilevskyy has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Serum L- and E-selectins as independent predictors of the adverse development and course of diabetic retinopathy in type 2 diabetes mellitus

    by A.V. Serdiuk, S.YU. Mogilevskyy, V.M. Serdiuk, M.S. Babenko, S.V. Ziablitsev

    Background. Endothelial activation and leukocyte-endothelium interactions are central to diabetic retinopathy (DR) and may underlie diabetic maculopathy (DMP). Serum markers for macular risk stratification remain limited. Aim of the study was to evaluate serum L- (LS) and E-selectins (ES) as independent predictors of the adverse development and course of diabetic retinopathy in type 2 diabetes mellitus. Materials and methods. Baseline cross-sectional analysis included 136 patients with type 2 diabetes and DR. DMP was assessed as present/absent (+/–); optical coherence tomography endpoints were central retinal thickness (CRT) and volume (CRV). LS and ES were measured by enzyme-linked immunosorbent assay. Linear and logistic regression (per +10 ng/mL) were adjusted for age, diabetes duration, systolic blood pressure, and DR stage; ROC analysis assessed discrimination. Results. DMP was present in 42.6 % of patients (58/136). LS and ES were higher in DMP+ than in DMP– (p < 0.001). After adjustment, both biomarkers were independently associated with higher CRT and CRV (p < 0.001) and predicted DMP (LS: odds ratio 4.14; ES: odds ratio 5.92 per +10 ng/mL; p < 0.001). Discrimination was excellent (AUC 0.900 for LS; 0.902 for ES); optimal cutoffs were LS ≥ 49.0 ng/mL and ES ≥ 55.9 ng/mL. For strictly defined diabetic macular edema, associations attenuated after adjustment for DR stage. Conclusions. LS and ES are strong independent predictors of DMP and worse optical coherence tomography structural outcomes in DR and may support pragmatic risk stratification.

  • Open Access

    Features of vitreoretinal surgery for idiopathic epiretinal membranes

    by Yu.O. Panchenko, A.O. Gulida, N.R. Lysenko, I.V. Verbytskyi, S.YU. Mogilevskyy

    Background. Idiopathic epiretinal membranes (ERM) are among the most common disorders of the vitreomacular interface and are one of the leading causes of reduced central vision in older patients. According to recent studies, the prevalence of ERM ranges from 7 to 39 %. With the aging of the population, the number of patients with symptomatic ERMs continues to increase, highligh­ting the high medical and social significance of this condition and the need to improve current treatments. Objective: to investigate the efficacy of contemporary combined and two-stage surgical approaches for the treatment of epiretinal membranes associated with age-related cataract. Materials and methods. The study included 150 patients (150 eyes) with ERM and initial age-related cataract, who were divided into two study groups. The mean age of the participants was 61.0 ± 2.3 years. In group 1 (81 eyes), 25-gauge closed subtotal vitrectomy (CSV) with ERM peeling was performed, followed by phacoemulsification 3 months later. In group 2 (69 eyes), CSV with combined ERM/internal limiting membrane (ILM) peeling was performed simultaneously with phacoemulsification and intraocular lens implantation. All patients underwent optical coherence tomo­graphy of the macular region, which was used to determine central retinal thickness, assess morphological changes in the macula, and detect the presence of an epiretinal membrane. Examinations were performed before surgery and at 1, 3, 6, and 12 months postoperatively. Results. Phacoemulsification in combination with vitreore­tinal surgery is associated with a higher incidence of macular edema in the early postoperative period. However, these changes were transient; their incidence decreased significantly after 3 months, and at one year, clinically significant macular edema was absent in all patients, regardless of the type of surgical intervention. This indicates a favorable long-term prognosis for both surgical approaches. Conclusions. Our studies demonstrated that CSV with ERM peeling only and CSV with combined ERM/ILM peeling, performed either without or with simultaneous cataract surgery, are effective methods for the treatment of ERM and result in improved visual function over a 1-year follow-up period. Phacoemulsification did not significantly improve visual acuity and, conversely, was associated with a higher incidence of persistent macular edema at 1 and 3 months postoperatively. ILM peeling did not improve functional outcomes after ERM surgery but reduced the risk of ERM recurrence.

  • Open Access

    Elevated baseline von Willebrand factor levels indicate greater disease severity and predict treatment failure in diabetic retinopathy

    by A.V. Serdiuk, S.YU. Mogilevskyy, M.S. Babenko, S.V. Ziablitsev

    Background. The search for systemic biomarkers capable of reflecting the activity of diabetic retino­pathy (DR) and predicting adverse treatment outcomes is an important clinical task of modern ophthalmology. Of particular interest is von Willebrand factor (vWF), which is a marker of endothelial dysfunction. Therefore, our aim was to evaluate the association of baseline vWF levels with the stage of DR and treatment failure, defined as rapid DR progression within 2 years, as well as to establish its potential prognostic utility in patients with type 2 diabetes mellitus (T2DM). Materials and methods. The study analyzed data from 136 T2DM patients with DR. DR stages were classified according to the WHO criteria as non-proliferative, pre-proliferative, and proliferative DR. The association of vWF with disease progression was assessed using ordinal and binary logistic regression models, adjusted for clinical confounders (age, sex, T2DM duration, glycated hemoglobin (HbA1c), systolic blood pressure, and baseline active ophthalmic treatment). Predictive utility was determined via ROC analysis with repeated stratified 5-fold cross-validation (50 repeats). Results. The presence of treatment failure was observed in 58.1 % of cases. vWF levels consistently increased with DR severity: 16.37 µg/mL in non-proliferative, 30.66 µg/mL in pre-proliferative, and 41.49 µg/mL in proliferative DR (p < 0.001). In treatment failure, vWF levels were significantly higher (34.26 µg/mL) compared to its absence (18.01 µg/mL; p < 0.001). In adjusted models, a 1 µg/mL increase in vWF independently increased the odds of a more severe DR stage (OR 1.23; p < 0.001) and treatment failure (OR 1.19; p < 0.001). The area under the ROC curve was 0.846; an optimal cut-off of 29.37 µg/mL yielded a sensitivity of 64.6 % and a specificity of 93.0 %. Conclusions. Baseline vWF levels demonstrate a consistent association with DR severity and represent a clinically relevant predictor for risk stratification of treatment failure in patients with T2DM.

  • Open Access

    Long-term results of excimer laser interventions in the combined treatment of keratoconus: 2 years of follow-up

    by S.YU. Mogilevskyy, I.V. Afanasiev, L.I. Denysiuk

    Background. Keratoconus is a common progressive corneal disorder that leads to a decline in visual function and quality of life. According to meta-analytical data, its prevalence is approximately 138 cases per 100,000 population. Current treatment strategies are aimed not only at stabilizing the ectatic process using corneal cross-linking (CXL), but also at improving functional outcomes through its combination with excimer laser procedures. However, the issues of long-term efficacy, stability of outcomes, and the impact of such combined approaches on visual function remain insufficiently investigated. The purpose was to evaluate the effectiveness of different excimer laser techniques as part of combined treatment for keratoconus over a 2-year follow-up period. Materials and methods. The study included 58 patients (64 eyes), comprising 40 men (69 %) and 18 women (31 %) aged 20 to 40 years. Participants were divided into two groups based on the intervention method. Group 1 underwent topography-guided photorefractive keratectomy combined with conventional (Dresden) crosslinking (TG-PRK with CXL). Group 2 included patients who underwent topography-guided transepithelial phototherapeutic keratectomy (without correction of the refractive component) with conventional (Dresden) crosslinking (TG t-PTK with CXL). Results. TG-PRK with CXL and TG t-PTK with CXL demonstrated a favorable safety profile and were effective in improving visual acuity over a long-term follow-up period. The incidence of most postoperative complications did not differ significantly between the groups. However, at 1 year postoperatively, the first group showed a significantly higher rate of corneal haze compared to the second group; these changes were transient and regressed within a 2-year follow-up period. Keratoconus progression was observed only in the first group, but the difference was not statistically significant. Best corrected visual acuity (BCVA) improved significantly after treatment, with a more stable effect observed in the second group over the long term. Uncorrected visual acuity (UCVA) demonstrated a temporary deterioration at 1 year, followed by a return to baseline values at 2 years. No statistically significant intergroup differences were found in UCVA or BCVA at any follow-up time point. Conclusions. The present study demonstrated that TG-PRK with CXL and TG t-PTK with CXL provided a favorable safety profile over a long-term follow-up period. The incidence of most complications did not differ significantly between the groups. However, at 1 year, a significantly higher rate of corneal haze was observed in the first group (23.5 vs 3 %, p = 0.029); these changes were transient and regressed within 2 years after the intervention. The low and statistically non-significant rate of keratoconus progression in the first group, along with the absence of intergroup differences, confirms the effectiveness of combined approach in stabilizing the ectatic process over a 2-year follow-up period. The applied treatment resulted in improved visual function in both groups. BCVA increased significantly, with a more stable long-term effect observed in the second group. UCVA showed a temporary deterioration at 1 year, followed by recovery to baseline values at 2 years. No statistically significant differences between the groups were found for UCVA or BCVA. Further investigation of novel risk factors, as well as etiolo­gical and pathogenetic mechanisms of keratoconus, may contribute to improving the effectiveness of treatment for this complex ocular disease.

  • Open Access

    Coagulation profile parameters as predictors of severe diabetic retinopathy and treatment inefficacy in patients with type 2 diabetes mellitus

    by A. V. Serdyuk, S. Y. Mogilevsky, M. S. Babenko, S. V. Ziablitsev

    Objective — to evaluate the clinical and prognostic significance of routine coagulation profile parameters as markers of severe proliferative diabetic retinopathy (PDR) and rapid diabetic retinopathy (DR) progression, and to establish practical cut-off values for risk stratification in patients with type 2 diabetes mellitus (T2DM). Materials and methods. A prospective cohort study was conducted involving 358 patients with T2DM and DR. According to the World Health Organization criteria (reclassified for the study), patients were categorized into non-proliferative/pre-proliferative DR (n=285) and PDR (n=73) groups. Based on 1 — 2 year follow-up dynamics, patients were classified into groups of non/slow progression (Grade 0 — 1, n=209) and rapid progression (Grade 2, n=149). The coagulation profile, including prothrombin time (PT), International Normalized Ratio (INR), activated partial thromboplastin time (APTT), fibrinogen, activated recalcification time (ART), prothrombin index (PTI), and thrombin time (TT), was assessed using standardized methods. Logistic regression and Receiver Operating Characteristic (ROC) analysis with Youden’s index calculation were performed. Results. Patients with PDR and those with rapid progression exhibited significantly higher levels of fibrinogen, prolonged PT, TT, and ART compared to controls (p < 0.01), while INR and APTT showed no significant differences. In univariate logistic regression, PT, Quick’s prothrombin, fibrinogen, ART, PTI, and TT were significant predictors of both severe DR and rapid progression. These associations persisted after adjustment for age, sex, T2DM duration, and blood pressure but lost statistical significance after further adjustment for glycated hemoglobin (HbA1c) (p ≥ 0.145), indicating the confounding/mediating role of glycemic control. ROC analysis revealed moderate discriminative ability for individual markers (AUC 0.60 — 0.66). However, the optimal cut-offs derived (e.g., ART > 75 s, fibrinogen > 459 mg/dL) demonstrated high specificity (> 90%) for identifying high-risk phenotypes. Conclusions. Severe DR and rapid disease progression in T2DM are associated with a prothrombotic profile characterized by elevated fibrinogen and altered clotting kinetics. These coagulation deviations are closely linked to poor glycemic control, serving as surrogate markers of metabolic decompensation rather than independent risk factors. Despite moderate overall sensitivity, the identified cut-off values for fibrinogen and recalcification time possess high specificity, supporting their potential clinical utility as «rule-in» criteria for prioritizing patients requiring intensified ophthalmological monitoring.

  • Open Access

    Atherogenic dyslipidemia (lipid fractions and simple lipid indices) as a predictor of diabetic macular edema and adverse optical coherence tomography outcomes in diabetic retinopathy

    by A.V. Serdiuk, S.YU. Mogilevskyy, M.S. Babenko, S.V. Ziablitsev

    Background. Diabetic macular edema (DME) is a major vision-threatening manifestation of diabetic retinopathy (DR), whereas pragmatic systemic markers for routine risk stratification are limited. Therefore, our aim was to evaluate associations of lipid fractions and simple lipid indices with DME and optical coherence tomography (OCT) outcomes and to identify practical cutoff values. Materials and methods. A cross-sectional analysis included 358 patients with type 2 diabetes mellitus and DR staged as non-proliferative/pre-proliferative/proliferative (52.8/26.8/20.4 %). DME was assessed as present/absent; OCT endpoints were central retinal thickness and volume. Lipid fractions comprised total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very-low-density lipoprotein cholesterol (VLDL-C), and triglycerides; indices included non-HDL-C, lipid ratios, and the atherogenic index of plasma. Nonparametric tests, logistic regression with odds ratios (ORs) adjusted for age, diabetes duration, and systolic blood pressure, and receiver operating characteristic analysis with area under the curve were applied. Results. DME prevalence was 19.6 % and increased from 5.8 % in non-proliferative DR to 49.3 % in proliferative DR (p for trend < 0.001). DME was associated with higher OCT metrics (both p < 0.001). In adjusted models, DME was associated with higher total cholesterol (OR 1.62), LDL-C (OR 1.62), VLDL-C (OR 5.32) and non-HDL-C (OR 1.51) per 1 mmol/L, whereas lipid ratios and atherogenic index of plasma were not significant. VLDL-C showed moderate discrimination (area under the curve 0.615; cutoff 1.05 mmol/L). Conclusions. Atherogenic lipid fractions, particularly VLDL-C and non-HDL-C, are linked to DME and worse OCT outcomes and warrant external validation.


  • Open Access

    THE PROGNOSTIC ROLE OF INTERLEUKIN 8 AND TRANSFORMING GROWTH FACTOR-β2 IN THE DEVELOPMENT OF DIFFUSE LAMELLAR KERATITIS AFTER EXCIMER LASER VISION CORRECTION USING LASIK AND Femto-LASIK METHODS

    by S.YU. Mogilevskyy, N.R. Lysenko

    Background. According to the literature, diffuse lamellar keratitis (DLK) develops in 4.3–37.5% of cases following excimer laser correction (ELC), with its pathogenesis modulated by the balance between proinflammatory interleukins and growth factors. Aim. To establish the prognostic role of interleukin-8 (IL-8) and transforming growth factor-β2 (TGF-β2) in the development of DLK after ELC using LASIK and Femto-LASIK methods. Material and methods. 180 patients (360 eyes) with myopia or myopia with myopic astigmatism were operated on. Patients in group 1 (182 eyes) underwent LASIK ELC, patients in group 2 (178 eyes) – Femto-LASIK. All patients were examined 1 week, 1 month, 1.5 and 2.5 years after ELC. In group 1, the number of cases with DLC at all observation periods was 29 (15.9%), in group 2 – 37 (20.8%). The control group included 10 patients from each group who did not develop DLC at any of the observation periods. The content of TGF-β2 and IL-8 in the tear fluid was determined by enzyme-linked immunosorbent assay. Results. In patients without DLC, the content of TGF-β2 and IL-8 in the tear fluid did not change significantly during the observation period. In patients with DLC, TGF-β2 was significantly increased (2.3-3.4 times compared to patients without DLC; p<0.05) at all time points, which was more pronounced when using the Femto-LASIK technique than LASIK. The content of IL-8 in patients with DLC was increased (2.3-3.4 times compared to patients without DLC; p<0.05), but only at early times (after 1 week – 3.1-3.2 times compared to control; p<0.05). The content of IL-8 in the LASIK and Femto-LASIK groups did not differ. After 1 week, but not at other times, a strong correlation between TGF-β2 and IL-8 was noted (r=+0.73; p=0.04). Both markers were associated with the development of DLC (for TGF-β2 r=+0.84, for IL-8 r=+0.60; p<0.001). Calculation of clinical Cut-Off thresholds for DLC development according to the Youden Index established a limit for TGF-β2 – 3237 pg/ml (sensitivity and specificity – 100%). The area under the ROC curve AUC=1.00 (95% CI 1.00-1.00), which indicated a very strong relationship between TGF-β2 content and DLC and the possibility of its use as a biomarker of DLC at all terms. Cut-Off for IL-8 was 4.02 pg/ml, the prognosis had satisfactory characteristics only at early terms. Conclusion. Thus, for the first time in the Ukrainian population, we have established the crucial importance of TGF-β2 accumulation for the development of DLC at different times (from 1 week to 2.5 years) after ELC by LASIK and Femto-LASIK methods.

  • Open Access

    Prediction of diabetic retinopathy based on determination of endothelial dysfunction factors

    by A.V. Serdyuk, S.YU. Mogilevsky, V.N. Serdyuk, A.O. Gulida, S.V. Ziablitsev

    Background. One of the main pathogenetic mechanisms of the onset and progression of diabetic retinopathy (DR) is endothelial dysfunction, which worsens ocular hemodynamics. Indicators of endothelial dysfunction correlate well with the seve­rity of DR and can be biomarkers of its progression. The purpose was to determine the content of endothelial dysfunction markers: high-sensitivity C-reactive protein (hs-CRP), endothelial monocyte-activating polypeptide-II (EMAP-II), endothelin-1 (ET-1), nitric oxide (NOx) metabolites, endothelial NO synthase (eNOS), interleukin-1β (IL-1β) and IL-6 at different stages of DR and the possibility of their use as diagnostic and prognostic markers. Materials and methods. One hundred and thirty-six patients with type 2 diabetes mellitus were examined and divided into groups: 1st one — with non-proliferative DR (60 eyes), 2nd one — with preproliferative DR (42 eyes) and 3rd one — with proliferative DR (34 eyes). The content of NOx in the blood was determined using the Gries reagent. Assessment of other markers in the serum was performed by the enzyme-linked immunoassay. The results were analyzed using the EZR v.1.54 package (Austria). Results. The blood content of the markers studied increased significantly that corresponded to the DR stages. The level of eNOS decreased significantly according to the DR stages. There was a strong correlation between all markers’ levels and the DR stages (r = –0.75 for eNOS and r = +0.52… +0.93 for the others; p < 0.0001). By constructing multivariate general linear models, 5 indicators were identified (hs-CRP, ET-1, NOx, IL-1β and IL-6), which had a very strong relationship with the resulting Y variable that characterized the DR stage (adjusted coefficient of determination R2adj = 0.94). For the Y variable, the cut-off values were obtained, which allowed predic­ting the DR stage (prediction accuracy was 96.3 %). The content of ET-1 and IL-6 in the blood (adjusted coefficient of determination R2adj = 0.91) had the greatest relationship with the resulting variable Y. The use of this model allowed predicting the stage of DR by the calculated indicator Y with an accuracy of 92.5 %. Conclusions. The indicators obtained corresponded to modern ideas about the role of endothelial dysfunction in the development and progression of DR; the possibility of their use as its biomarkers was established. The presented two-factor mathematical model allows implemen­ting the evaluation of ET-1 and IL-6 content thresholds to diagnose the DR stages.

  • Open Access

    C-reactive protein as a possible diagnostic and prognostic factor of diabetic retinopathy

    by A.V. Serdiuk, S.YU. Mogilevskyy, S.V. Ziablitsev

    Background. Current data show an important role of C-reactive protein (CRP) in the onset and progression of diabetic retinopathy (DR), which necessitated the study of using its serum content as a possible contributing factor. Aim of the study was to determine the content of CRP at different stages of DR and the possibility of using it as a prognostic factor of its progression. Materials and methods. 136 patients with type 2 diabetes mellitus were examined and divided into groups: first — with non-proliferative DR (NPDR; 60 eyes), second — with preproliferative DR (PPDR; 42 eyes) and third — with proliferative DR (PDR; 34 eyes). Patients were examined and treated for 2 years. Serum content (in μg/l) of high-sensitivity (hs) CRP was determined by the enzyme-linked immunosorbent assay. The analysis of the study results was performed in the EZR v.1.54 package (Austria). Results. Patients with type 2 diabetes and DR reported a significant increase in serum hs-CRP compared to individuals without diabetes. In NPDR, it exceeded the control level by 1.9 times, in PPDR — by 3.2 times, in PDR — by 4.9 times (p < 0.001 for all comparisons). The selection of optimal thresholds for multi-class classification by the One-vs-All method with the construction of receiver operating characteristic (ROC) curves determined the cut-off levels of hs-CRP at different stages of DR. Values less than 1977 μg/l were characteristic of the control group. In patients with NPDR, the indicators ranged from 1978 to 3683.5 μg/l, in PPDR — from 3683.6 to 5523 μg/l, and in PDR, they were more than 5523 μg/l. The content of hs-CRP directly correlated with fasting glycemia (r = 0.194), central retinal thickness (r = 0.517) and volume (r = 0.486), glycated hemoglobin (r = 0.774), total cholesterol (r = 0.385), high-density lipoprotein (r = 0.260), low-density lipoprotein (r = 0.361), and very low-density lipoprotein (r = 0.493), as well as triglycerides (r = 0.374). The risk of DR progression after 2 years of observation increased 2.3 times for every 1000 μg/l increase in the hs-CRP blood content (p < 0.001; odds ratio = 2.33; 95% confidence interval (CI) 1.74–3.14). The area under the ROC curve was 0.84 (95% CI 0.77–0.90), the sensitivity of the model was 69.6 % (95% CI 60.7–81.8), specificity — 91.2 % (95% CI 83.7–97.4). Conclusions. The results obtained justify the possibi­lity of using C-reactive protein as a highly informative biomarker for diagnosing the stage of DR and predicting its progression.

  • Open Access

    Endothelin-1 as a biomarker of diabetic retinopathy and a factor in its progression

    by S.Yu. Mogilevskyy, A.V. Serdiuk, S.V. Ziablitsev

    Background. In modern conditions, the development of simple screening programs using available indicators that can be used as biomarkers is highly relevant. Potentially, endothelin-1 (ET-1), which is involved in the mechanisms of early vascular disorders in diabetic retinopathy (DR), can be considered as such. Aim of the study was to determine the content of ET-1 at different stages of DR and the possibility of its use as a diagnostic and prognostic factor of DR progression. Materials and methods. 136 patients with type 2 diabetes mellitus were examined and divided into groups: 1st — non-proliferative (NPDR, 60 eyes), 2nd — preproliferative DR (PPDR; 42 eyes) and 3rd — proliferative DR (PDR; 34 eyes). Patients were examined and treated for 2 years. ET-1 in blood serum was determined by enzyme-linked immunosorbent assay. The results were analyzed in the EZR v. 1.54 package (Austria). Results. In patients with type 2 diabetes and DR, a significant increase in the content of blood ET-1 was found compared to the control group without diabetes. In NPDR, it exceeded the control level by 2.2 times, in PPDR and PDR — by 3.8–4.1 times (p < 0.001). The content of ET-1 in PPDR and PDR did not differ (p > 0.05) but was higher than in NPDR (by 1.7–1.9 times; p < 0.05). Thus, in the development of DR, ET-1 had two peaks — the first one in the NPDR development (the threshold level is above 1.015 pg/ml) and the second one — in the further NPDR progression (more than 2.0 pg/ml; the accuracy of the prediction is 92.5 %). ET-1 content had direct relationships with systolic (r = 0.512) and diastolic pressure (r = 0.432), fasting glycemia (r = 0.187), central retinal thickness (r = 0.491) and volume (r = 0.478), levels of glycated hemoglobin (r = 0.566), total cholesterol (r = 0.352) and its fractions. The risk of DR progression after 2 years of observation increased with increasing ET-1 content (p < 0.001; odds ratio 5.18; 95% confidence interval 2.69–9.98). Conclusions. The obtained results confirmed and specified the possibility of using ET-1 level in the blood as a highly informative biomarker of NPDR and the prognosis of its progression.